Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

NCT03339336 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

265

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to close study early; not due to safety concerns

Conditions

Small Fiber Neuropathy
Diabetes Mellitus

Interventions

DRUG: BIIB074
DRUG: Placebo

Sponsor

Biogen